Literature DB >> 11796639

In vivo modifications of small GTPase Rac and Cdc42 by Bordetella dermonecrotic toxin.

Minako Masuda1, Masayoshi Minami, Hiroaki Shime, Takeshi Matsuzawa, Yasuhiko Horiguchi.   

Abstract

Bordetella dermonecrotic toxin (DNT) is known to activate the small GTPase Rho through deamidation or polyamination. In this study, we examined whether Rac and Cdc42, the two other members of the Rho family, serve as intracellular targets for the toxin. Immunoprecipitation and immunoblot assays revealed that DNT deamidated or polyaminated intracellular Rac and Cdc42. After the modifications, both Rac and Cdc42 lost their GTP-hydrolyzing, but not GTP-binding, activities. The interactions of the modified Rac and Cdc42 with their respective effectors were strictly dependent on GTP. MC3T3-E1 cells treated with DNT at high concentrations demonstrated extensive formations of lamellipodia and filopodia, which indicate the intracellular activation of Rac and Cdc42, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796639      PMCID: PMC127728          DOI: 10.1128/IAI.70.2.998-1001.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.

Authors:  A J Ridley; H F Paterson; C L Johnston; D Diekmann; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  Effects of Bordetella bronchiseptica dermonecrotic toxin on the structure and function of osteoblastic clone MC3T3-e1 cells.

Authors:  Y Horiguchi; T Nakai; K Kume
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

3.  Effects of Bordetella bronchiseptica dermonecrotizing toxin on bone formation in calvaria of neonatal rats.

Authors:  Y Horiguchi; T Okada; N Sugimoto; Y Morikawa; J Katahira; M Matsuda
Journal:  FEMS Immunol Med Microbiol       Date:  1995-09

4.  Stimulation of DNA synthesis in osteoblast-like MC3T3-E1 cells by Bordetella bronchiseptica dermonecrotic toxin.

Authors:  Y Horiguchi; N Sugimoto; M Matsuda
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  A brain serine/threonine protein kinase activated by Cdc42 and Rac1.

Authors:  E Manser; T Leung; H Salihuddin; Z S Zhao; L Lim
Journal:  Nature       Date:  1994-01-06       Impact factor: 49.962

6.  Bordetella bronchiseptica dermonecrotizing toxin stimulates protein synthesis in an osteoblastic clone, MC3T3-E1 cells.

Authors:  Y Horiguchi; N Sugimoto; M Matsuda
Journal:  FEMS Microbiol Lett       Date:  1994-07-01       Impact factor: 2.742

7.  Activation of rho through a cross-link with polyamines catalyzed by Bordetella dermonecrotizing toxin.

Authors:  M Masuda; L Betancourt; T Matsuzawa; T Kashimoto; T Takao; Y Shimonishi; Y Horiguchi
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

8.  Identification of a novel Rac1-interacting protein involved in membrane ruffling.

Authors:  L Van Aelst; T Joneson; D Bar-Sagi
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

9.  Characterization of rhoGAP. A GTPase-activating protein for rho-related small GTPases.

Authors:  C A Lancaster; P M Taylor-Harris; A J Self; S Brill; H E van Erp; A Hall
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

10.  Bordetella bronchiseptica dermonecrotizing toxin stimulates assembly of actin stress fibers and focal adhesions by modifying the small GTP-binding protein rho.

Authors:  Y Horiguchi; T Senda; N Sugimoto; J Katahira; M Matsuda
Journal:  J Cell Sci       Date:  1995-10       Impact factor: 5.285

View more
  9 in total

Review 1.  Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Future Microbiol       Date:  2010-08       Impact factor: 3.165

Review 2.  Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

3.  Transglutaminase in Receptor and Neurotransmitter-Regulated Functions.

Authors:  Nancy A Muma
Journal:  Med One       Date:  2018-12-05

4.  Association of Bordetella dermonecrotic toxin with the extracellular matrix.

Authors:  Aya Fukui-Miyazaki; Shigeki Kamitani; Masami Miyake; Yasuhiko Horiguchi
Journal:  BMC Microbiol       Date:  2010-09-25       Impact factor: 3.605

5.  Mycobacterium avium genes MAV_5138 and MAV_3679 are transcriptional regulators that play a role in invasion of epithelial cells, in part by their regulation of CipA, a putative surface protein interacting with host cell signaling pathways.

Authors:  Melanie J Harriff; Lia Danelishvili; Martin Wu; Cara Wilder; Michael McNamara; Michael L Kent; Luiz E Bermudez
Journal:  J Bacteriol       Date:  2008-12-05       Impact factor: 3.490

6.  Identification of a receptor-binding domain of Bordetella dermonecrotic toxin.

Authors:  Takeshi Matsuzawa; Takashige Kashimoto; Jun Katahira; Yasuhiko Horiguchi
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

7.  Transglutaminase activation in neurodegenerative diseases.

Authors:  Thomas M Jeitner; Nancy A Muma; Kevin P Battaile; Arthur Jl Cooper
Journal:  Future Neurol       Date:  2009-07-01

8.  Histaminylation of glutamine residues is a novel posttranslational modification implicated in G-protein signaling.

Authors:  Jakob Vowinckel; Silke Stahlberg; Nils Paulmann; Katharina Bluemlein; Maik Grohmann; Markus Ralser; Diego J Walther
Journal:  FEBS Lett       Date:  2012-09-26       Impact factor: 4.124

9.  Bordetella Dermonecrotic Toxin Is a Neurotropic Virulence Factor That Uses CaV3.1 as the Cell Surface Receptor.

Authors:  Shihono Teruya; Yukihiro Hiramatsu; Keiji Nakamura; Aya Fukui-Miyazaki; Kentaro Tsukamoto; Noriko Shinoda; Daisuke Motooka; Shota Nakamura; Keisuke Ishigaki; Naoaki Shinzawa; Takashi Nishida; Fuminori Sugihara; Yusuke Maeda; Yasuhiko Horiguchi
Journal:  mBio       Date:  2020-03-24       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.